血管形成術治療患者における局所循環単核前駆細胞を用いた切断の予測

1:33

Flow-Mediated Dilation (FMD) Evaluation

2:11

Lower Limb Vascular Blood Evaluation, Blood Sampling, and Balloon Angioplasty

4:07

Circulating Mononuclear Progenitor Cell (MPC) Isolation and Antibody Staining

5:21

MPC Quantification

6:10

Results: Representative Relationship Between MPC and Hemodynamic Indicators and Lower Limb Amputation Prognosis After Angioplasty

7:04

Conclusion